These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 8750552)

  • 21. Randomised trial of plasma exchange, intravenous immunoglobulin, and combined treatments in Guillain-Barré syndrome. Plasma Exchange/Sandoglobulin Guillain-Barré Syndrome Trial Group.
    Lancet; 1997 Jan; 349(9047):225-30. PubMed ID: 9014908
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Guillain-Barré syndrome. A clinical electrophysiological and biochemical study.
    Kaur U; Chopra JS; Prabhakar S; Radhakrishnan K; Rana S
    Acta Neurol Scand; 1986 Apr; 73(4):394-402. PubMed ID: 3727915
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prognostic factors in Guillain-Barre' syndrome.
    Singh NK; Jaiswal AK; Misra S; Srivastava PK
    J Assoc Physicians India; 1994 Oct; 42(10):777-9. PubMed ID: 7876046
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Clinico-electrophysiological profile and predictors of functional outcome in Guillain-Barre syndrome (GBS).
    Verma R; Chaudhari TS; Raut TP; Garg RK
    J Neurol Sci; 2013 Dec; 335(1-2):105-11. PubMed ID: 24064258
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Epidemiology of the Guillain-Barré syndrome in the county of Hordaland, Western Norway.
    Larsen JP; Kvåle G; Nyland H
    Acta Neurol Scand; 1985 Jan; 71(1):43-7. PubMed ID: 3872003
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [The Landry-Guillain-Barré syndrome. Study of prognostic factors in 223 cases].
    Raphael JC; Masson C; Morice V; Brunel D; Gajdos P; Barois A; Goulon M
    Rev Neurol (Paris); 1986; 142(6-7):613-24. PubMed ID: 3797932
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Survey of Guillain-Barré syndrome in southern Finland.
    Färkkilä M; Kinnunen E; Weckström P
    Neuroepidemiology; 1991; 10(5-6):236-41. PubMed ID: 1798424
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Clinical and epidemiologic features of Guillain-Barré syndrome.
    Hughes RA; Rees JH
    J Infect Dis; 1997 Dec; 176 Suppl 2():S92-8. PubMed ID: 9396689
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Epidemiology of Guillain-Barré syndrome in children: relationship of oral polio vaccine administration to occurrence.
    Rantala H; Cherry JD; Shields WD; Uhari M
    J Pediatr; 1994 Feb; 124(2):220-3. PubMed ID: 8301426
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Plasma exchange treatment and prognosis of Guillain-Barré syndrome.
    Smith GD; Hughes RA
    Q J Med; 1992 Oct; 85(306):751-60. PubMed ID: 1287706
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Exogenous gangliosides and Guillain-Barré syndrome. An observational study in the local health district of Ferrara, Italy.
    Govoni V; Granieri E; Tola MR; Paolino E; Casetta I; Fainardi E; Monetti VC
    Brain; 1997 Jul; 120 ( Pt 7)():1123-30. PubMed ID: 9236625
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Guillain-Barré syndrome and its relationship to swine influenza vaccination in Michigan, 1976-1977.
    Breman JG; Hayner NS
    Am J Epidemiol; 1984 Jun; 119(6):880-9. PubMed ID: 6731430
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Guillain-Barré syndrome without sensory loss (acute motor neuropathy). A subgroup with specific clinical, electrodiagnostic and laboratory features. Dutch Guillain-Barré Study Group.
    Visser LH; Van der Meché FG; Van Doorn PA; Meulstee J; Jacobs BC; Oomes PG; Kleyweg RP; Meulstee J
    Brain; 1995 Aug; 118 ( Pt 4)():841-7. PubMed ID: 7655882
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Age and Guillain-Barré syndrome severity.
    Sheth RD; Riggs JE; Hobbs GR; Gutmann L
    Muscle Nerve; 1996 Mar; 19(3):375-7. PubMed ID: 8606705
    [No Abstract]   [Full Text] [Related]  

  • 35. [Clinical and neurophysiologic study of Guillain Barré syndrome: results of therapy with plasmapheresis].
    Fasanaro AM; Pizza V; Florio C; Tancredi G; Fabbri P; Aiello L; Viscidi E; Rossi V; Vacca C
    Riv Neurol; 1991; 61(1):39-45. PubMed ID: 1857922
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The prognosis and main prognostic indicators of Guillain-Barré syndrome. A multicentre prospective study of 297 patients. The Italian Guillain-Barré Study Group.
    Brain; 1996 Dec; 119 ( Pt 6)():2053-61. PubMed ID: 9010009
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Increased incidence of Guillain-Barré syndrome postpartum.
    Cheng Q; Jiang GX; Fredrikson S; Link H; de Pedro-Cuesta J
    Epidemiology; 1998 Nov; 9(6):601-4. PubMed ID: 9799167
    [TBL] [Abstract][Full Text] [Related]  

  • 38. National surveillance for Guillain-Barré syndrome: January 1978-March 1979.
    Hurwitz ES; Holman RC; Nelson DB; Schonberger LB
    Neurology; 1983 Feb; 33(2):150-7. PubMed ID: 6681655
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Neuromuscular respiratory failure in Guillain-Barre Syndrome: evaluation of clinical and electrodiagnostic predictors.
    Sundar U; Abraham E; Gharat A; Yeolekar ME; Trivedi T; Dwivedi N
    J Assoc Physicians India; 2005 Sep; 53():764-8. PubMed ID: 16334619
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Guillain-Barré syndrome in the northern area of Gran Canaria and the island of Lanzarote].
    Aladro-Benito Y; Conde-Sendin MA; Muñoz-Fernández C; Pérez-Correa S; Alemany-Rodríguez MJ; Fiuza-Pérez MD; Alamo-Santana F
    Rev Neurol; 2002 Oct 16-31; 35(8):705-10. PubMed ID: 12402219
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.